Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lopez-Berestein

Showing results (1-10 of 285) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|October 1, 2005
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cellsBulent Ozpolat, Kapil Mehta, Gabriel Lopez-Berestein
Mini Reviews in Medicinal Chemistry|March 14, 2008
Strategies for in vivo siRNA delivery in cancerAngela Sanguino, Gabriel Lopez-Berestein, Anil K Sood
Advanced Drug Delivery Reviews|January 4, 2014
Liposomal siRNA nanocarriers for cancer therapyBulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Methods in Enzymology|June 3, 2004
Liposomal antisense oligonucleotides for cancer therapyDoris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002Doris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Cancers|October 14, 2020
Aptamers: Novel Therapeutics and Potential Role in Neuro-OncologyPaola Amero, Soumen Khatua, Cristian Rodriguez-Aguayo, et al.
Non-Coding RNA|September 22, 2023
Non-Coding RNAs: Foes or Friends for Targeting Tumor MicroenvironmentAnna Szymanowska, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, et al.
American Journal of Hematology|May 8, 2002
all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemiaBulent Ozpolat, Kapil Mehta, Ana M Tari, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 20, 2003
Development of liposomal polyene antibiotics: an historical perspectiveAgatha W K Ng, Kishor M Wasan, Gabriel Lopez-Berestein
Pageof 29

Showing results (1-10 of 285) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|October 1, 2005
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cellsBulent Ozpolat, Kapil Mehta, Gabriel Lopez-Berestein
Mini Reviews in Medicinal Chemistry|March 14, 2008
Strategies for in vivo siRNA delivery in cancerAngela Sanguino, Gabriel Lopez-Berestein, Anil K Sood
Advanced Drug Delivery Reviews|January 4, 2014
Liposomal siRNA nanocarriers for cancer therapyBulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Methods in Enzymology|June 3, 2004
Liposomal antisense oligonucleotides for cancer therapyDoris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002Doris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Cancers|October 14, 2020
Aptamers: Novel Therapeutics and Potential Role in Neuro-OncologyPaola Amero, Soumen Khatua, Cristian Rodriguez-Aguayo, et al.
Non-Coding RNA|September 22, 2023
Non-Coding RNAs: Foes or Friends for Targeting Tumor MicroenvironmentAnna Szymanowska, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, et al.
American Journal of Hematology|May 8, 2002
all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemiaBulent Ozpolat, Kapil Mehta, Ana M Tari, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 20, 2003
Development of liposomal polyene antibiotics: an historical perspectiveAgatha W K Ng, Kishor M Wasan, Gabriel Lopez-Berestein
Pageof 29